Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies

Immune checkpoint inhibitors block the checkpoint molecules. Different types of cancer immune checkpoint inhibitors have been approved recently: CTLA-4 monoclonal antibodies (as ipilimumab); anti-PD-1 monoclonal antibodies (as pembrolizumab and nivolumab); and anti-PD-L1 monoclonal antibodies (as at...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Silvia Martina, Fallahi, Poupak, Elia, Giusy, Ragusa, Francesca, Ruffilli, Ilaria, Patrizio, Armando, Galdiero, Maria Rosaria, Baldini, Enke, Ulisse, Salvatore, Marone, Gianni, Antonelli, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566424/
https://www.ncbi.nlm.nih.gov/pubmed/31137683
http://dx.doi.org/10.3390/ijms20102560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566424/
https://www.ncbi.nlm.nih.gov/pubmed/31137683
http://dx.doi.org/10.3390/ijms20102560

Ejemplares similares